We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.26B
AUM Growth
+$69.7M
Cap. Flow
+$21.1M
Cap. Flow %
1.68%
Top 10 Hldgs %
3.22%
Holding
2,074
New
640
Increased
457
Reduced
456
Closed
520

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$3.54M
2
MNST icon
Monster Beverage
MNST
+$3.4M
3
UGI icon
UGI
UGI
+$3.25M
4
LMND icon
Lemonade
LMND
+$3.18M
5
APA icon
APA Corp
APA
+$3.05M

Top Sells

Rank Stock Value
1
CRH icon
CRH
CRH
+$4.73M
2
AON icon
Aon
AON
+$4.58M
3
ZG icon
Zillow
ZG
+$4.44M
4
URNM icon
Sprott Uranium Miners ETF
URNM
+$4.08M
5
BWXT icon
BWX Technologies
BWXT
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 12.61%
3 Healthcare 12.06%
4 Consumer Discretionary 11.89%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABEO icon
1426
Abeona Therapeutics
ABEO
$413M
$178K 0.01%
+24,561
New +$156K
IGMS
1427
DELISTED
IGM Biosciences
IGMS
$178K 0.01%
+18,398
New +$213K
DCGO icon
1428
DocGo
DCGO
$62.6M
$176K 0.01%
+43,512
New +$164K
NKLA
1429
DELISTED
Nikola Corporation Common Stock
NKLA
$176K 0.01%
+5,627
New +$121K
CDXS icon
1430
Codexis
CDXS
$158M
$173K 0.01%
49,630
-787,406
-94% -$2.48M
OSW icon
1431
OneSpaWorld
OSW
$2.66B
$171K 0.01%
+12,950
New +$175K
KLRS
1432
Kalaris Therapeutics
KLRS
$96.8M
$171K 0.01%
9,853
+776
+9% +$12.7K
SGU icon
1433
Star Group
SGU
$423M
$168K 0.01%
+16,757
New +$186K
ZNTL icon
1434
Zentalis Pharmaceuticals
ZNTL
$302M
$167K 0.01%
+10,602
New +$146K
FMNB icon
1435
Farmers National Banc Corp
FMNB
$930M
$163K 0.01%
+12,231
New +$165K
BRFS
1436
DELISTED
BRF SA
BRFS
$162K 0.01%
+49,844
New +$147K
EARN
1437
Ellington Residential Mortgage REIT
EARN
$165M
$161K 0.01%
23,304
-24,803
-52% -$153K
DVAX
1438
DELISTED
Dynavax Technologies
DVAX
$158K 0.01%
+12,725
New +$166K
MRSN
1439
DELISTED
Mersana Therapeutics
MRSN
$158K 0.01%
+1,410
New +$140K
ALTO icon
1440
Alto Ingredients
ALTO
$340M
$156K 0.01%
+71,454
New +$151K
AMCR icon
1441
Amcor
AMCR
$22.1B
$156K 0.01%
+3,283
New +$154K
CNTA
1442
DELISTED
Centessa Pharmaceuticals
CNTA
$154K 0.01%
+13,587
New +$129K
VLN icon
1443
Valens Semiconductor
VLN
$188M
$154K 0.01%
65,692
+24,807
+61% +$56.3K
ULBI icon
1444
Ultralife
ULBI
$106M
$153K 0.01%
+17,337
New +$141K
ARCO icon
1445
Arcos Dorados Holdings
ARCO
$1.74B
$152K 0.01%
+13,672
New +$162K
PHAT icon
1446
Phathom Pharmaceuticals
PHAT
$692M
$151K 0.01%
+14,174
New +$120K
VZIO
1447
DELISTED
VIZIO Holding Corp.
VZIO
$151K 0.01%
13,777
+3,416
+33% +$31.3K
PTEN icon
1448
Patterson-UTI
PTEN
$3.76B
$148K 0.01%
12,398
-14,516
-54% -$161K
ITI
1449
DELISTED
Iteris, Inc.
ITI
$148K 0.01%
+29,961
New +$148K
FHTX icon
1450
Foghorn Therapeutics
FHTX
$360M
$147K 0.01%
21,855
-19,440
-47% -$108K
56 57
58
59 60

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q1 2024 Portfolio in Review

As of Q1 2024, GSA Capital Partners held 2,074 positions worth $1.26B, up 5.9% from $1.19B the previous quarter. Its ten largest holdings account for 3.2% of the portfolio.

GSA Capital Partners's Q1 2024 filing shows 640 new, 457 increased, 456 reduced and 520 closed positions. Its largest new stake was Zoetis: 18,907 shares worth $3.2M. The largest sale was CRH, an estimated $4.73M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • GSA Capital Partners's largest Q1 2024 buy was Zoetis: 18,907 shares worth $3.2M.
  • GSA Capital Partners added most to Monster Beverage in Q1 2024, an estimated $3.4M increase.
  • GSA Capital Partners's biggest Q1 2024 reduction was CRH, cutting an estimated $4.73M.
  • GSA Capital Partners fully exited Aon in Q1 2024, selling an estimated $4.58M.
  • GSA Capital Partners's ten largest holdings make up 3.2% of its $1.26B portfolio in Q1 2024.
  • GSA Capital Partners opened 640 new positions and closed 520 in Q1 2024.
  • GSA Capital Partners's portfolio value rose 5.9% quarter-over-quarter to $1.26B.

Based on GSA Capital Partners's 13F filing for Q1 2024, filed 3 May 2024.